ocunexus.comBioTechFounded: 1900Funding to Date: $144.36MM
Ocunexus Therapeutics is a biotechnology company focused on inflammasome modulation for treatment of Dry Age-related Macular Degeneration and Diabetic Retinopathy.
For more details on financing and valuation for OcuNexus Therapeutics, register or login.
Already registered? Click here to log in
To read this article and more news on OcuNexus Therapeutics, register or login.
Already registered? Click here to log in.
Forge and SharesPost have teamed up to provide you with an enhanced trading experience.